Ilumya (tildrakizumab)

18,161.00

Ilumya (tildrakizumab) is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections, pills (systemic therapy), or phototherapy (treatment using ultraviolet or UV light).

DISEASE INDICATIONS

Psoriasis

MANUFACTURER

Almirall, S.A.

USAGE

Subcutaneous

MEDICINE APPROVED BY

  • European Medical Agency (EMA)

  • Food and Drug Administration (FDA)

    PATIENTS HELPED

    • Over 1.2 million patients reached

    • More than 11,000 patients helped

    • 100% successful deliveries to 88 countries

This content has been reviewed by a Medical Doctor.
ILUMYA (TILDRAKIZUMAB) Package Single-dose syringe

One syringe of 100 mg/ml

Reviews

There are no reviews yet.

Be the first to review “Ilumya (tildrakizumab)”

Your email address will not be published. Required fields are marked *

Shopping Cart